adult asthma patients will soon have a newtreatment available to them. i'm shelby cullinan your latest health news. the us fda approved breo ellipta, which isan inhaled corticosteroid, to treat asthma. the once-daily asthma treatment from glaxosmithkline,or gsk, and theravance inc. is only approved for use in adults. the fda approved breo elliptaafter the drug was studied in more than 12,000 patients in 23 trials and appeared safe andeffective. according to gsk, breo ellipta may raise patients' risk of certain hearteffects, such as increased pulse, raised blood pressure and irregular heartbeat. speak toyou doctor about the best treatment option for you.